Condition
Metastasis to Liver
Total Trials
6
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Unknown3
Withdrawn2
Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT06317181Not ApplicableRecruiting
Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data
NCT04274790Withdrawn
Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer
NCT05681949Not ApplicableUnknown
Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards
NCT05790590Not ApplicableUnknownPrimary
Comparison of Image Quality Between "Double Low Dose" Liver CT and Standard Liver CT
NCT02581670Not ApplicableUnknown
Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer
NCT04280640Withdrawn
Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes
Showing all 6 trials